Last Updated on August 14, 2023 by The Health Master
Aurobindo Pharma Ltd. has received final approval from the U.S. Food and Drug Administration (USFDA) to manufacture and market Vancomycin Hydrochloride, a drug that is used to treat infections such as those of the skin and bones.
The approval was granted by the USFDA to Eugia Pharma Specialities Ltd., a wholly owned subsidiary of the company.
Vancomycin Hydrochloride, for injections, is supplied in single-dose vials of 1.25 grams and 1.5 grams, the company said in a press release.
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon: